# Visual and technical review — 28 October 2026

Scope: existing Arabic `/demo` interface, original purple/teal design, no UI edits and no build. Captures are synthetic only. The local review server used loopback port 5174 because 5173 was occupied. Source under `src/` remains identical to `b86ec06`.

## Review result

The dashboard preserves a coherent pharmacy workflow: clear patient/dispensing statistics, an explicit critical-allergy priority, visible next actions and a persistent synthetic-data notice. Desktop navigation, tablet horizontal navigation and stacked mobile forms remain usable. No visual redesign is needed for the controlled synthetic test phase.

| Surface | Measured result | Visual observation |
|---|---|---|
| Desktop 1440×1000 | document width 1434px, RTL | Four statistic tiles and a full right sidebar; priorities and actions remain distinct. |
| Tablet 768×1024 | document width 762px, RTL | Horizontal pill navigation; four compact tiles remain readable and panels fit. |
| Phone 390×844 | document width 384px, RTL | Two-column statistics, stacked content, no horizontal page overflow. |
| Phone medication form | document width 384px | Editor precedes medication list, focused medicine control, vertically stacked fields; refill timeline has no `open` attribute. |

Scrollbar width accounts for the six-pixel difference. Horizontal scrolling is intentionally inside navigation, not the page. Current phone/tablet body font measured 16px. This inspection is not a physical Android test or a complete screen-reader/WCAG certification.

## Scoped audit health

| Dimension | Score / 4 | Evidence and limits |
|---|---:|---|
| Accessibility | 3 | Explicit labels, focus ring and preserved status text; secondary sign-in target is small. Full screen-reader/text-scaling checks remain. |
| Performance | 2 | Lazy workflow bundles/local fonts exist; all-resource loading and whole-workspace refresh remain a scaling gap. No new benchmark/build was run. |
| Responsive design | 3 | Current three-size inspection and previous four-viewport tests pass; Android keyboard/orientation/text scaling remain untested. |
| Theming | 3 | Coherent tokens and purple/teal surfaces; some component-level colors remain literal. Dark mode is outside this brief. |
| Implementation integrity | 3 | Patient/allergy/refill UI is product-specific and coherent. The bundled detector was unavailable earlier; no successful detector or full conformity result is claimed. |
| Total | **14/20** | **Good within this limited interface scope; not a clinical release decision.** |

Integrity verdict: scoped pass for a coherent pharmacy interface; conditional on the operational/clinical gates in SAAS_READINESS. This is a new review of unchanged UI, not a replacement for independent accessibility or safety evaluation.

## Verified findings

- **[P2, Responsive/A11y] Small secondary sign-in target:** the demo strip's sign-in link measured 14px high on phone and 17px on tablet. It has space around it, so this alone is not asserted as a WCAG failure. Increase its hit area toward 44px in a later approved refinement. Location: `src/App.tsx`, demo strip. Suggested command: `$impeccable adapt`.
- **[P2, Performance] Full resource loading/refresh:** `src/data/repository.ts` loads every 200-row page of each resource before displaying the workspace; `src/App.tsx` invalidates it after each write. Narrow queries/aggregates and measured larger-tenant acceptance are needed before scale. Suggested command: `$impeccable optimize`.
- **[P2, Responsive] Physical-phone acceptance remains open:** desktop emulation does not prove soft-keyboard, orientation, scaling or secure-context behavior over Wi-Fi. The HTTPS guide is prepared; no phone/CA/firewall configuration was performed. Suggested command: `$impeccable harden`.

No P0 visual blocker or P1 defect was established in the inspected surfaces. Clinical/privacy blockers are separately documented and must not be hidden by this visual disposition. Maintain explicit allergy wording, ingredient-check limitations, readable contrast and direct access to every module.

Recommended later sequence: `$impeccable adapt` for the small secondary target, `$impeccable optimize` for measured scale work, `$impeccable harden` for real-device states, then `$impeccable polish`. These are recommendations, not work authorized/executed in this phase. You can ask for them one at a time or in any order; rerun `$impeccable audit` after fixes.

## Evidence

- [Desktop](evidence/pilot-review/desktop-dashboard.jpg)
- [Tablet](evidence/pilot-review/tablet-dashboard.jpg)
- [Phone](evidence/pilot-review/mobile-dashboard.jpg)
- [Patient list](evidence/pilot-review/mobile-patients.jpg)
- [Medication editor](evidence/pilot-review/mobile-medication-editor.jpg)
- [DOM layout measurements](evidence/pilot-review/layout-metrics.json)
